Browser not supported
Please use the latest version of Microsoft Edge, Firefox, Safari or Google Chrome to access this application.
Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases.
Read onOur robust research and development engine allows us to discover therapies that could have a profound impact on patient health.
Read onOur goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries.
Read onTo achieve our mission to repeatedly bring important new medicines to patients with serious diseases, we remain committed to running our business responsibly and operating with the highest standards of integrity. This commitment underscores our philosophy of ‘doing well by doing good,’ every day.
Read on